
News|Articles|October 5, 2007
FDA to hold public meeting on behind-the-counter drugs
FDA seeks comments on behind-the-counter drugs
Advertisement
The FDA has posted a notice in the Oct. 3 Federal Register, announcing a public meeting on Nov. 14 to obtain comments regarding behind-the-counter (BTC) availability of drugs. The purpose of the meeting is to solicit information and views on specific issues associated with BTC availability, including increased patient access to safe and effective drug products. The agency is interested in obtaining public comments as it explores the public health benefit of certain drugs being available BTC without a prescription, but only after intervention by a pharmacist.
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Pharmacists Take Control of Medical Billing
2
Pharmacists Essential for Managing Patient Safety in Self-Medication
3
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
4
COVID-19 Booster Comparison Shows Higher Antibody Levels With mRNA Vaccine
5






























